North Bay Eye Associates | Petaluma, CA

Research site

(Unclaimed)

Location

104 Lynch Creek, Suite 12, Petaluma, California, United States of America

Site insights

Top conditions

Top treatments

Latanoprost

Netarsudil

Timolol Maleate

Bimatoprost

DE-117

Azithromycin

KPI-121

RVL-1201

AGN-195263

DE-126

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 53 total trials

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

This is a randomized, double-blind, two-treatment, single-period, parallel design, multiple dose at multiple clinical trial sites designed to demonst...

Enrolling

Ocular Hypertension

Glaucoma, Open-Angle

Drug: Test - Bimatoprost 0.01% Ophthalmic Solution

Drug: Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)

Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients with Open-angle Glaucoma or Ocular Hypertension

The main purpose is to compare the ocular hypotensive efficacy and safety of two concentrations of T4090 (Kinezodianone R HCl 0.2% and 0.3%) ophthalm...

Active, not recruiting

Glaucoma

Ocular Hypertension

Drug: Rhopressa®

Drug: T4090 0.3%

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR (Maia)

This study will evaluate the long-term safety and efficacy of Bimatoprost Sustained Release (SR) in patients with open-angle glaucoma or ocular hyper...

Invitation-only

Open-Angle Glaucoma

Ocular Hypertension

Drug: Bimatoprost SR

Other: Standard of Care

Next Generation Rocklatan

The purpose of this two-stage clinical trial is to assess the safety and hypotensive efficacy of AR-17043 and PG043 ophthalmic solutions in subjects...

Enrolling

Open Angle Glaucoma

Ocular Hypertension

Drug: AR-17043 Ophthalmic Solution

Drug: Netarsudil 0.02%/Latanoprost 0.005% Ophthalmic Solution

Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction

This study evaluates the reliability, validity and safety of a self administered, subjective refraction test via a mobile medical app (GoEyes) as com...

Enrolling

Refractive Errors

Diagnostic Test: Mobile medical application to self administer a subjective refraction test

Diagnostic Test: Standard of care refraction test